COTY.NYSECoty INC

10-K: Coty Reports Fiscal 2025 Net Loss Amid Market Headwinds

Sentiment:

Annual Report


Coty Inc. reported a significant net loss of $367.9 million for fiscal year 2025, driven by asset impairment charges and declining revenues in key beauty segments.

Worse than expectedNet revenues decreased 4% in fiscal 2025, indicating a decline in sales.The company reported a net loss of $367.9 million in fiscal 2025, a significant negative shift from net income in the prior year.Operating income decreased by 56%, primarily due to substantial asset impairment charges ($212.8 million) and a loss on the KKW Collaboration Agreement termination ($71.0 million).Cash provided by operating activities decreased by $122.0 million, reflecting higher cash outflows from working capital.The company incurred significant net losses on forward repurchase contracts ($291.7 million) and an unfavorable fair market value adjustment related to the Wella investment ($83.0 million).

Summary

  • Net revenues decreased 4% to $5,892.9 million in fiscal 2025 compared to $6,118.0 million in fiscal 2024.
  • The company incurred a net loss attributable to Coty Inc. of $367.9 million in fiscal 2025, a significant decline from a net income of $89.4 million in fiscal 2024.
  • Operating income decreased by 56% to $241.1 million in fiscal 2025 from $546.7 million in fiscal 2024.
  • Asset impairment charges totaled $212.8 million in fiscal 2025, primarily affecting Max Factor, CoverGirl, Bourjois, and Philosophy trademarks.
  • Prestige segment net revenues decreased 1% to $3,820.2 million, while Consumer Beauty segment net revenues decreased 8% to $2,072.7 million.
  • Gross profit decreased to $3,820.9 million in fiscal 2025 from $3,939.2 million in fiscal 2024, though gross margin percentage slightly increased to 35.2% from 35.6%.
  • Selling, general and administrative expenses decreased 2% to $3,103.4 million, but increased as a percentage of net revenues to 52.7% from 51.7%.
  • The company incurred a loss of $71.0 million on the termination of the KKW Collaboration Agreement.
  • Cash provided by operating activities decreased to $492.6 million in fiscal 2025 from $614.6 million in fiscal 2024.
  • Total debt increased to $4,008.4 million as of June 30, 2025, from $3,913.7 million as of June 30, 2024.
  • JAB Investors beneficially own approximately 54% of the outstanding Class A Common Stock, maintaining Coty's 'controlled company' status under NYSE rules.

Sentiment

Score: 3

Explanation: The company experienced a significant net loss and a decline in net revenues in fiscal 2025, primarily due to substantial asset impairment charges and losses on forward repurchase contracts. While there are some positives like improved gross margin percentage and growth in prestige fragrances, the overall financial performance is weak, and the future outlook for H1 fiscal 2026 indicates continued revenue decline. The increased debt and ongoing tariff impacts also contribute to a negative sentiment.

Positives

  • Gross margin percentage increased by approximately 40 basis points in fiscal 2025, driven by decreased excess and obsolescence costs and improved manufacturing efficiencies and procurement.
  • Prestige fragrance sales grew by $64.9 million in fiscal 2025, supported by successful existing lines (Burberry, Gucci, Chloe, Hugo Boss) and new innovations.
  • Mass fragrance sales grew by $27.9 million due to geographical expansion and brand innovation.
  • The company successfully transitioned mass fragrance production and plans additional transfers of entry-level prestige fragrance products to its U.S. manufacturing site.
  • Adjusted operating income margin increased to 14.5% in fiscal 2025 from 14.1% in fiscal 2024, and Adjusted EBITDA margin increased to 18.4% from 17.8%.
  • The company maintains a robust cybersecurity risk management program, including regular incident simulations and Board oversight.
  • The company was in compliance with all debt covenants as of June 30, 2025.

Negatives

  • Net revenues decreased 4% in fiscal 2025, primarily due to declines in color cosmetics and mass body care.
  • The company reported a net loss of $367.9 million in fiscal 2025, a significant reversal from net income in the prior year.
  • Operating income decreased by 56% in fiscal 2025, largely due to $212.8 million in asset impairment charges and a $71.0 million loss on the KKW Collaboration Agreement termination.
  • Prestige cosmetic sales declined by $55.3 million, impacted by economic conditions in Asia and regulations affecting surrogate shopping.
  • Prestige skincare sales declined by $18.1 million due to negative performance from the Philosophy brand.
  • Mass color cosmetics sales declined by $161.7 million due to weakening market demand in the U.S. and Europe, impacting Covergirl, Sally Hansen, and Rimmel.
  • Mass body care sales declined by $61.4 million, primarily from Monange in Brazil due to competitive pricing and Adidas in Mexico and Brazil.
  • Net revenue in the Asia Pacific region declined by a high-single digit percentage due to economic challenges in China and a decline in the Asia Travel Retail channel.
  • Cash provided by operating activities decreased by $122.0 million in fiscal 2025, mainly due to higher cash outflows from working capital.
  • The company incurred $291.7 million in net losses on forward repurchase contracts in fiscal 2025, and an unfavorable fair market value adjustment of $83.0 million related to the Wella investment.
  • The effective tax rate was (1.6)% in fiscal 2025, negatively impacted by increased valuation allowances on interest expense carryforwards and capital loss from KKW Holdings sale, and changes in unrecognized tax benefits.

Risks

  • The beauty industry is highly competitive and rapidly changing due to consumer preferences, digital expansion, new brands, and technological advances like AI.
  • Further consolidation in the retail industry and shifting consumer preferences to e-commerce may adversely affect business.
  • Product safety or quality failures, actual or perceived, or allegations of product contamination could tarnish brand image and lead to recalls or litigation.
  • Brand licenses may be terminated if specified conditions are not met, or may not be renewed on favorable terms.
  • Inability to obtain, maintain, and protect intellectual property rights, or the failure of brand partners/licensors to do so, could negatively impact competitiveness.
  • Business is subject to seasonal variability, with higher sales during the winter holiday season, making it vulnerable to inaccurate forecasting during these periods.
  • Failure to successfully implement global business strategies, including cost reduction and deleveraging, could adversely affect financial results.
  • New product introductions may not be as successful as anticipated, leading to lower revenues and margins.
  • Acquisition activities and strategic transactions present managerial, integration, operational, and financial risks, potentially preventing the realization of intended benefits.
  • Joint ventures and strategic partnership investments involve risks such as inconsistent interests, non-fulfillment of obligations, financial difficulties of partners, and lack of full control.
  • Goodwill and other assets have been subject to impairment and may continue to be in the future, particularly if business performance declines or expected growth is not realized.
  • Disruptions in operations, including industrial accidents, labor disputes, supply chain issues, or loss of key manufacturing/distribution sites, could adversely affect business.
  • Dependence on third-party service providers for outsourced functions (e.g., distribution, finance, IT) exposes the company to risks of failure or disruption.
  • Increasing dependence on information technology and the inability to protect against service interruptions, data corruption, cyber-based attacks, or network security breaches could disrupt operations.
  • Challenges with properly managing the use of AI could harm brands, reputation, business, or customers.
  • Success depends on attracting and retaining key personnel, and unexpected loss or inability to do so could adversely affect business.
  • Underestimating or overestimating demand for products and not maintaining appropriate inventory levels could negatively impact net revenues or working capital.
  • International operations expose the company to political, regulatory, economic, and reputational risks, including inflation, recession, and geopolitical conflicts.
  • Additional tariffs or other restrictions on imports, retaliatory trade measures, and resulting trade wars may materially adversely impact financial condition.
  • Changes in tax laws or regulations, or challenges to tax positions, could significantly increase tax liabilities.
  • Significant debt and associated covenants impose operating and financial restrictions, increasing vulnerability to adverse economic conditions.
  • Ability to service and repay indebtedness is dependent on subsidiary cash flow and events beyond control, with potential for refinancing difficulties.
  • Variable rate indebtedness subjects the company to interest rate risk, which could cause debt service obligations to increase.
  • General economic downturns, credit constriction, global economic/political uncertainties, or sudden business disruptions may affect consumer spending and supply chains.
  • Price inflation for labor, materials, and services, exacerbated by geopolitical events, could adversely affect business and financial condition.
  • Volatility in financial markets could have a material adverse effect on business and securities trading price.
  • Fluctuations in currency exchange rates may negatively impact financial condition and results of operations.
  • Subject to legal proceedings and compliance risks, including talc-related litigation alleging bodily injury, with increasing settlement values and costs.
  • Changes in laws, regulations, and policies affecting business or products could adversely affect financial results and share price.
  • Employees or others may engage in misconduct or improper activities, including noncompliance with regulatory standards, leading to liabilities or reputational harm.
  • Violations of harassment policies could result in liabilities and/or litigation.
  • If the P&G Beauty Business acquisition or related distribution does not qualify for intended tax treatment, the company may be required to indemnify P&G for substantial tax-related losses.
  • Stock repurchase program or its discontinuation could affect stock price and increase volatility, and forward repurchase contracts expose the company to risks related to stock price movements and true-up payments.
  • JAB Investors' majority ownership (54%) gives them significant influence over decisions, potentially conflicting with other stockholders' interests.
  • As a controlled company, Coty is exempt from certain NYSE corporate governance requirements, potentially reducing protections for other stockholders.
  • Dual-listing on NYSE and Euronext Paris may adversely affect liquidity and value of Class A Common Stock.

Future Outlook

The company expects reported net revenue for the first half of fiscal 2026 to decline in the low-single digit percentage, including a low-single digit percentage benefit from foreign exchange. Gross margin is anticipated to be pressured in the first half of fiscal 2026 due to lower sales and the net impact from tariffs, with some easing in the second half due to mitigation efforts. Cost reduction efforts are being re-accelerated to deliver approximately $80.0 million in savings in fiscal 2026. Reported net revenue for the second half of fiscal 2026 is expected to return to growth, supported by major launches in both Prestige and Consumer Beauty segments and more favorable comparisons. The company aims to continue expanding its footprint in structurally profitable beauty categories and geographic markets, leveraging its leadership in global fragrances. Skincare remains a strategic focus, but achieving scale will take time and mindful investment. The company expects to suspend common stock dividends until a Net debt to Adjusted EBITDA target of 2x is approached, while continuing to pay cash dividends on Series B Convertible Preferred Stock quarterly.

Management Comments

  • We have sharpened our priorities to capitalize on structural tailwinds in the fragrance market.
  • We are leveraging our leadership in fragrance innovation, licensing, and manufacturing to expand across price points, from mass to ultra-premium and across scenting formats.
  • With slower growth in China's beauty market, we have shifted focus to a broader set of emerging markets and the U.S.
  • In Consumer Beauty, we aim to improve performance and profitability through agile innovation, social media advocacy, and expansion into body mists and masstige fragrances.
  • Skincare remains a strategic focus, but achieving scale takes time, and we will pursue this while remaining very mindful of the investment demands.
  • We also continue to advance key sustainability priorities.
  • We are continually benchmarking the performance of our supply chain, and we augment our supply base, adjust our distribution networks and manufacturing footprint, enhance our forecasting and planning capabilities and adjust our inventory strategy based upon the changing needs of the business.
  • We remain focused on deleveraging our balance sheet using cash flows generated from our operations.
  • We expect to continue to take actions to improve the maturity mix of our debt, including through refinancings or new issuances of notes, as well as redemptions and/or tender offers for near-dated maturities, from time to time as market conditions permit.

Industry Context

The beauty industry is highly competitive and rapidly evolving, influenced by digital channels, direct-to-consumer sales, niche brands, and technological advancements like AI. While prestige fragrances and skincare categories have shown strong growth, the retail mass color cosmetics, mass nail, and mass fragrance categories in the U.S. and parts of Western Europe are experiencing declines. Global economic uncertainties, geopolitical conflicts (e.g., Ukraine, Middle East), and inflationary pressures continue to impact consumer spending and supply chains. The company is adapting its strategy by focusing on fragrance leadership, expanding into growth channels like e-commerce and travel retail, and diversifying into profitable beauty categories, while also shifting focus from China to broader emerging markets and the U.S. due to slower growth in China's beauty market.

Comparison to Industry Standards

  • The fragrance category experienced low-single digit percentage net revenue growth, which is slower than the high-single digit percentage growth in the overall fragrance market, indicating underperformance relative to the market.
  • Declines in mass color cosmetics and prestige color cosmetics are noted, contrasting with the general market trends where some competitors might be gaining share or maintaining stability in these segments.
  • The company's gross margin percentage increase of 40 basis points, driven by efficiencies, suggests effective cost management in a challenging environment, potentially outperforming less agile competitors in this aspect.
  • The significant asset impairment charges on key brands like Max Factor, CoverGirl, Bourjois, and Philosophy indicate underperformance or reduced future expectations for these brands, which may lag behind industry leaders in their respective categories.
  • The company's strategic shift from China to other emerging markets and the U.S. acknowledges the slower growth in China's beauty market, a trend that other global beauty companies like L'Oréal and Estée Lauder are also navigating, though their specific strategies and outcomes may differ.
  • The company's efforts to leverage AI tools for media allocation and content creation align with broader industry trends of digital transformation and data analytics adoption seen in major beauty players.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Controlled Company StatusJAB Investors beneficially own approximately 54% of outstanding Class A Common Stock, qualifying Coty as a controlled company under NYSE rules. This allows exemptions from certain corporate governance requirements, such as a majority of independent directors on the Board and fully independent nominating and compensation committees.As of June 30, 2025May reduce protections for stockholders compared to companies subject to all NYSE independence rules, though the Stockholders Agreement includes obligations for Board and committee independence.
Stockholders Agreement AmendmentThe Stockholders Agreement with JAB Investors was amended and restated as of June 16, 2023. Key provisions include a three-year restriction on JAB acquiring additional shares beyond approximately 69% beneficial ownership, a one-year restriction on JAB transferring shares to a new largest beneficial owner, requirements for Disinterested Director Approval and majority stockholder vote (excluding JAB) for Rule 13e-3 transactions, and Disinterested Director Approval for material related party transactions.2023-06-16Provides some safeguards for minority shareholders regarding control changes and related party transactions, but JAB retains significant influence over the company's decisions and management appointments.
Board CompositionThe Stockholders Agreement requires maintaining no fewer than four Independent Directors on the Board for as long as the agreement is in effect.OngoingAims to ensure a level of independent oversight despite the controlled company status.
Lead Independent Director AppointmentThe company shall appoint a new lead independent director consistent with the terms of the Stipulation of Settlement.Not specified, but ongoing commitmentEnhances independent leadership within the Board structure.
Cybersecurity GovernanceThe Board of Directors has delegated oversight responsibility for cybersecurity and data privacy to the Audit and Finance Committee (AFC) and established a dedicated Cybersecurity Special Committee. The Special Committee, led by the Chief Information, Digital Innovation and Business Services Officer and two Board members, manages responses to major cybersecurity incidents.OngoingStrengthens the company's ability to manage and respond to cybersecurity risks, integrating crisis management and business continuity processes.

Legal Proceedings

  • The company is involved in various litigation, administrative, and other legal proceedings, including consumer class actions, personal injury (talc-related), intellectual property, competition, compliance, and advertising claims.
  • Talc-related litigation: Numerous civil actions allege cosmetic talcum powder products were contaminated with asbestos, leading to bodily injury. Settlement values and costs have increased due to the rising number of cases and evolving litigation landscape. The company believes it has valid defenses and some costs may be covered by insurance, but the ultimate resolution is uncertain and could negatively affect profitability and brand image.
  • Brazilian Tax Assessments: Brazilian subsidiaries face tax assessments from local, state, and federal authorities. As of June 30, 2025, estimated amounts include R$726.5 million (approx. $132.6 million) for Gois State sales tax credits, R$469.4 million (approx. $85.7 million) for Federal excise taxes (2016-2017), R$639.5 million (approx. $116.7 million) for Federal excise taxes (2018-2019), R$36.0 million (approx. $6.6 million) for Federal excise taxes (2020), and R$242.4 million (approx. $44.2 million) for Minas Gerais State sales taxes. The company has provided surety bonds and cash deposits totaling approximately $172.0 million to guarantee payment for some cases and is seeking favorable judicial and administrative decisions, believing it has meritorious defenses.
  • Gois State tax ICMS assessment (August 2020): A related judicial case regarding an additional claim for 'Protege Fee' received unfavorable rulings, with appeals filed to the Brazilian Superior Court of Justice. A motion to suspend tax collection was dismissed, and a judge ruled against the company in Q4 fiscal 2024. An interlocutory appeal is pending. An additional case for underlying ICMS taxes due to non-payment of the Protege Fee moved to judicial court in October 2024, with a tax enforcement filed in Q3 fiscal 2025. Surety bonds of R$446.2 million (approx. $81.4 million) have been provided for this case.

Related Party Transactions

  • Performance Guarantee: The company assigned rights and obligations under a real estate lease to JAB Partners LLP, remaining secondarily liable for up to approximately $3.3 million if the assignee defaults. The probability of default is assessed as remote.
  • Equity Transfer Agreement: JAB Beauty B.V. transferred 10.0 million and 5.0 million shares of Class A Common Stock to CEO Sue Nabi on October 29, 2021, and September 18, 2023, respectively, as part of her one-time sign-on award.
  • Relationship with KKR: KKR Aggregator previously held Series B Preferred Stock and had director designation rights, but has fully redeemed/exchanged all shares. KKR funds may still hold the company's Senior Secured and Unsecured Notes.
  • Wella: Coty owns 25.84% of Wella Company. The company recognized gains of $10.1 million in fiscal 2025 from post-closing adjustments to the Wella Business purchase consideration. The Transitional Services Agreement (TSA) with Wella ended January 31, 2022, and distribution services in Brazil ended in fiscal 2024, but manufacturing arrangements continue. TSA and other fees earned from Wella were $0.2 million and $5.0 million, respectively, in fiscal 2025. Management, consulting, and financial services fees earned were $1.2 million in fiscal 2025. Accounts receivable from Wella were $34.6 million and accounts payable were $0.4 million as of June 30, 2025. The company has accrued $35.1 million related to long-term payables due to Wella. Sublease income from Wella was $7.6 million in fiscal 2025. Share-based compensation expense for Wella employees was $0.7 million in fiscal 2025.
  • Consulting Services: Director Beatrice Ballini was a senior member at Russell Reynolds Associates, which provided $0.9 million in recruiting services to the company in fiscal 2023. Russell Reynolds Associates is no longer a related party as of fiscal 2024.

Stakeholder Impact

  • Shareholders: Experienced a significant net loss in fiscal 2025, a decline in share price, and potential dilution from future share repurchases. Common stock dividends remain suspended, impacting shareholder returns. JAB Investors' majority ownership gives them significant control.
  • Employees: Subject to restructuring and business realignment plans (Fixed Cost Reduction Plan) which may involve employee separations. The company emphasizes human capital, training, and health and safety programs. Key personnel retention is a risk.
  • Customers: Impacted by declining sales in certain beauty categories and geographic regions. Pricing adjustments are being considered to offset tariff pressures, which could affect customer purchasing decisions. Supply chain disruptions could impact product availability.
  • Suppliers: The company is optimizing its supply chain and evaluating diversified sourcing strategies, which could affect existing supplier relationships. Efforts to improve payable terms could also impact supplier relations. Compliance with ethical and environmental standards is expected from suppliers.
  • Creditors: The company has significant debt and is focused on deleveraging. Debt covenants impose restrictions, and the ability to service and repay debt depends on cash flow generation. Refinancing activities could lead to higher interest rates or more onerous covenants.
  • Regulatory Bodies: The company is subject to various U.S. and international regulations, including new EU sustainability-related laws (CSRD, EUDR, CSDDD) and U.S. state climate disclosures, increasing compliance efforts and costs. Ongoing legal proceedings, including talc-related litigation and Brazilian tax assessments, pose potential liabilities.

Next Steps

  • Re-accelerate cost reduction efforts to deliver approximately $80.0 million in savings in fiscal 2026.
  • Implement major product launches across both Prestige and Consumer Beauty segments in the second half of fiscal 2026.
  • Continue to thoughtfully expand the skincare portfolio, mindful of investment demands.
  • Evaluate expanded regionalization strategies, including potential additional U.S. investments, to optimize the supply chain.
  • Collaborate with external partners to strengthen domestic manufacturing capabilities.
  • Monitor economic and geopolitical conditions and take actions to address impacts on Consumer Beauty brands in China.
  • Refinance 2026 Dollar Senior Secured Notes and 2026 Euro Senior Secured Notes (maturing April 2026) on a long-term basis through existing revolving credit facility or new note issuances.
  • Redeem Series A Preferred Stock at $0.01 per share.
  • Continue to pay dividends in cash on Series B Convertible Preferred Stock on a quarterly basis.
  • Continue to pursue deleveraging agenda and implement strategic initiatives, aiming for a Net debt to Adjusted EBITDA target of 2x before resuming common stock dividends.
  • The next three tranches of 2,083,333 PRSUs will be granted on or around each September 1 of 2025 through 2027, vesting on the third-year anniversary of the respective grant date.

Key Dates

DateDescription
2015-04-17Certificate of Designations of Preferred Stock, Series A, dated.
2015-04-20Certificate of Designations of Preferred Stock, Series A, filed.
2015-07-21Board granted Mr. Becht an award of 300,000 phantom units.
2015-07-24Mr. Becht elected to receive payment of phantom units in Class A Common Stock.
2016-10-01Closing of the acquisition of the P&G Beauty Business and effective date of the Tax Matters Agreement.
2017-03-27Series A Preferred Stock subscription agreement entered into with Lambertus J.H. Becht.
2018-04-05Company entered into an amended and restated credit agreement (2018 Coty Credit Agreement).
2018-04-05Company issued $550.0 million of 6.50% senior unsecured notes due 2026, 550.0 million of 4.00% senior unsecured notes due 2023, and 250.0 million of 4.75% senior unsecured notes due 2026.
2019-03-17Company became party to a stockholders agreement with JAB Holdings B.V., JAB Cosmetics B.V. and JAB Beauty B.V.
2019-03-19Company entered into an Uncommitted Receivables Purchase Agreement with a financial institution.
2019-09Company entered into a factoring agreement with a financial institution for European receivables.
2020-04-29Board of Directors suspended the payment of dividends on common stock.
2020-05Company filed a Certificate of Designations establishing Series B Convertible Preferred Stock.
2020-05-26Certificate of Designations for Series B Convertible Preferred Stock filed with the Secretary of State of Delaware.
2021-01-04Company completed its purchase of 20% of the outstanding equity of KKW Holdings, LLC.
2021-04-21Company issued $900.0 million of 5.00% senior secured notes due 2026.
2021-06-16Company issued 700.0 million of 3.875% senior secured notes due 2026.
2021-06-30CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units.
2021-07Company entered into foreign exchange forward contracts to hedge euro denominated external debt.
2021-08-27KKR Aggregator and its affiliated investment funds sold 146,057 shares of Series B Preferred Stock to HFS Holdings S. r.l.
2021-08-31First tranche of CEO's RSU award vested and settled in 10.0 million shares.
2021-09-30Redemption Agreement dated with KKR Rainbow Aggregator L.P.
2021-10-29JAB completed the transfer of 10.0 million shares of Common Stock to Ms. Nabi.
2021-11-06Redemption Agreement dated with KKR Rainbow Aggregator L.P.
2021-11-30Company issued $500.0 million of 4.75% senior secured notes due 2029.
2021-12-31KKR fully redeemed/exchanged all of their Series B Preferred Stock.
2022-04-27Board of Directors announced decision to wind down Russian operations.
2022-06Company entered into forward repurchase contracts to hedge for potential $200.0 million share buyback program in 2024.
2022-08-31Second tranche of CEO's RSU award vested and settled in 10.0 million shares.
2022-12Company entered into forward repurchase contracts to hedge for potential $196.0 million share buyback program in 2025.
2023-072018 Coty Credit Agreement amended.
2023-07-26Company issued $750.0 million of 6.625% senior secured notes due 2030.
2023-08-22Amended Employment Agreement for Sue Nabi filed.
2023-08-31Third tranche of CEO's RSU award vested and settled in 5.0 million shares.
2023-09-18JAB completed the transfer of 5.0 million shares of Common Stock to Ms. Nabi.
2023-09-19Company issued 500.0 million of 5.750% senior secured notes due 2028.
2023-09-28Board determined three-year performance objectives for first tranche of CEO's PRSU award.
2023-09-29Company issued 33.0 million shares of Class A common stock in a global offering.
2023-10-02Company issued 33.0 million shares of Class A common stock in a global offering.
2023-11Company entered into forward repurchase contracts to hedge for potential $294.0 million share buyback program in 2026.
2023-11-13Board increased share repurchase authorization by an additional $600.0 million.
2023-12-07Company redeemed $150.0 million of the 2026 Dollar Notes.
2023-12Interest rate swap contracts fully terminated for a cash receipt of $2.1 million.
2024-02Company physically settled the June 2022 forward repurchase contract for $200.0 million cash in exchange for 27.0 million shares.
2024-03-27Exchange right for Series A Preferred Stock expired.
2024-04-02U.S. administration announced additional tariffs.
2024-05-30Company issued 500.0 million of 4.50% senior secured notes due 2027.
2024-05-30Company redeemed the remaining $323.0 million of the 2026 Dollar Notes.
2024-09Senior Secured Notes achieved investment grade ratings from two ratings agencies, triggering collateral release and covenant suspension provisions.
2024-10Price of Coty's Class A Common Stock declined, triggering a potential Hedge Valuation Adjustment event under the November 2023 forward repurchase contracts.
2024-10-02Board determined three-year performance objectives for second tranche of CEO's PRSU award.
2024-11Company entered into agreements for a temporary contractual amendment to the November 2023 forward repurchase contracts' Hedge Valuation Adjustment mechanism.
2024-12-06Company redeemed the remaining 180.3 million (approximately $190.6 million) of the 2026 Euro Notes.
2024-12-10Company completed its cash tender offer and redeemed $300.0 million of the 2026 Dollar Senior Secured Notes.
2024-12Company entered into an agreement to extend the maturity date of the December 2022 forward repurchase contracts by one year to fiscal 2026.
2025-01Company entered into cross-currency swap contracts in the notional amount of $750.0 million and 676.9 million (Swiss Franc).
2025-02Price of Coty's Class A shares declined, triggering cash settlements under December 2022 and amended November 2023 forward repurchase contracts of $191.1 million.
2025-03-21KKW Collaboration Agreement terminated pursuant to the KKW Sale Agreement.
2025-03-31Company sold and derecognized its 20% equity investment in KKW Holdings.
2025-04Company entered into cross-currency swap contracts in the notional amount of $250.0 million and 203.6 million.
2025-04-24Company announced a new Fixed Cost Reduction Plan.
2025-08-01U.S. administration announced additional tariffs.
2025-08A reduction in the price of Coty's Class A Common Stock triggered additional payments under remaining forward repurchase contracts.
2025-08-21Annual Report on Form 10-K filed.
2025-09-0115% of Ms. Nabi's 10,416,667 RSUs will vest.
2025-09-01Next tranche of 2,083,333 PRSUs will be granted to Ms. Nabi.
2025-12-15Repurchase date for December 2022 forward repurchase contracts.
2025-12-31Repurchase date for November 2023 forward repurchase contracts.
2026-042026 Dollar Senior Secured Notes and 2026 Euro Senior Secured Notes are scheduled to mature.
2026-07The One Big Beautiful Bill Act, including changes to U.S. tax law, will be applicable to the Company.
2026-09-0115% of Ms. Nabi's 10,416,667 RSUs will vest.
2026-09-01First tranche of Ms. Nabi's PRSU award of 2,083,333 shares will fully vest.
2026-09-01Next tranche of 2,083,333 PRSUs will be granted to Ms. Nabi.
2027-09-0120% of Ms. Nabi's 10,416,667 RSUs will vest.
2027-09-01Second tranche of Ms. Nabi's PRSU award of 2,083,333 shares will fully vest.
2027-09-01Next tranche of 2,083,333 PRSUs will be granted to Ms. Nabi.
2028-07-11Maturity date for the 2023 Coty Revolving Credit Facility.
2028-09-0130% of Ms. Nabi's 10,416,667 RSUs will vest.
2028-12-31Earliest exercise date for the Put and Call rights on the Middle East Subsidiary noncontrolling interest.
2029-12-31Closing date for the Put and Call rights on the Middle East Subsidiary noncontrolling interest.

Recommendation

hold

Coty Inc. faces significant headwinds, including a substantial net loss in fiscal 2025 driven by asset impairment charges and losses on forward repurchase contracts. While the company is implementing strategic initiatives to improve profitability, such as cost reduction plans and focusing on high-growth fragrance categories, the near-term outlook for revenue growth remains challenged, with a projected decline in the first half of fiscal 2026. The increased debt load and ongoing legal and regulatory risks, particularly the talc-related litigation and Brazilian tax assessments, add considerable uncertainty. The 'controlled company' status and JAB's majority ownership also present governance considerations. Given the mixed financial performance, the significant non-cash charges, and the ongoing strategic transformation with uncertain outcomes, a 'hold' recommendation is appropriate. Investors should monitor the execution of the Fixed Cost Reduction Plan, the success of new product launches, progress on deleveraging, and the resolution of legal contingencies before making further investment decisions.

Keywords

Beauty, Fragrance, Cosmetics, Skincare, SEC Filing, 10-K, Financial Results, Coty, Consumer Beauty, Prestige, Asset Impairment, Debt, Share Repurchase, Corporate Governance, Risk Factors, Supply Chain, E-commerce, Sustainability, JAB Investors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.